Abnormal autophagy, HA, IR, obesity, impaired ecdysis and aberrant expression of relevant tolerance markers were found to have an impact on endometrial receptivity in patients with PCOS
To overcome these limitations, advanced drug delivery systems, particularly nanotechnology-based approaches, have emerged as promising solutions
One significant finding is from the SELECT trial, which showed that long-term use of semaglutide in individuals with obesity but without diabetes led to a 20% reduction in major cardiovascular events and an average weight loss of 9.4%
Some cosmetic companies market AHK-Cu as a next-generation copper peptide with improved stability, but these claims have not been rigorously validated in independent comparative studies
Scholz D, Pltl D, Genewsky A, Weng M, Waldmann T, Schildknecht S, et al